ProPhase Labs, Inc.
PRPH
$0.3326
$0.00130.39%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.43M | -1.21M | 3.15M | 2.47M | 2.36M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.43M | -1.21M | 3.15M | 2.47M | 2.36M |
| Cost of Revenue | 905.00K | -1.76M | 3.31M | 2.95M | 2.42M |
| Gross Profit | 526.00K | 551.00K | -165.00K | -476.00K | -60.00K |
| SG&A Expenses | 4.09M | 15.72M | 7.65M | 7.21M | 7.30M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.09M | 14.03M | 11.08M | 10.30M | 9.99M |
| Operating Income | -3.66M | -15.23M | -7.94M | -7.83M | -7.63M |
| Income Before Tax | -4.68M | -16.71M | -9.10M | -8.44M | -8.09M |
| Income Tax Expenses | -- | 14.56M | -2.51M | -2.29M | -2.57M |
| Earnings from Continuing Operations | -4.68M | -31.26M | -6.59M | -6.15M | -5.52M |
| Earnings from Discontinued Operations | 8.64M | -3.10M | -- | -- | -741.00K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 3.97M | -34.36M | -6.59M | -6.15M | -6.27M |
| EBIT | -3.66M | -15.23M | -7.94M | -7.83M | -7.63M |
| EBITDA | -2.18M | -14.66M | -5.55M | -6.21M | -6.03M |
| EPS Basic | 0.11 | -1.59 | -0.35 | -0.33 | -0.35 |
| Normalized Basic EPS | -0.08 | -0.42 | -0.30 | -0.28 | -0.28 |
| EPS Diluted | 0.11 | -1.58 | -0.35 | -0.33 | -0.35 |
| Normalized Diluted EPS | -0.08 | -0.42 | -0.30 | -0.28 | -0.28 |
| Average Basic Shares Outstanding | 35.23M | 20.46M | 19.08M | 18.89M | 18.05M |
| Average Diluted Shares Outstanding | 35.23M | 20.46M | 19.08M | 18.89M | 18.05M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |